GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Beneish M-Score

Quest Diagnostics (BSP:Q1UE34) Beneish M-Score : -2.58 (As of Apr. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Quest Diagnostics's Beneish M-Score or its related term are showing as below:

BSP:Q1UE34' s Beneish M-Score Range Over the Past 10 Years
Min: -2.85   Med: -2.62   Max: -2.35
Current: -2.58

During the past 13 years, the highest Beneish M-Score of Quest Diagnostics was -2.35. The lowest was -2.85. And the median was -2.62.


Quest Diagnostics Beneish M-Score Historical Data

The historical data trend for Quest Diagnostics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Beneish M-Score Chart

Quest Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.64 -2.35 -2.73 -2.85 -2.58

Quest Diagnostics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 -2.67 -2.53 -2.58 -

Competitive Comparison of Quest Diagnostics's Beneish M-Score

For the Diagnostics & Research subindustry, Quest Diagnostics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's Beneish M-Score falls into.



Quest Diagnostics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Quest Diagnostics for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0989+0.528 * 1.026+0.404 * 0.9959+0.892 * 0.9172+0.115 * 0.9898
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8987+4.679 * -0.03563-0.327 * 1.0383
=-2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was R$6,583 Mil.
Revenue was 11782.207 + 11210.742 + 11334.317 + 11347.951 = R$45,675 Mil.
Gross Profit was 3839.426 + 3606.253 + 3723.78 + 3844.13 = R$15,014 Mil.
Total Current Assets was R$11,095 Mil.
Total Assets was R$69,488 Mil.
Property, Plant and Equipment(Net PPE) was R$11,897 Mil.
Depreciation, Depletion and Amortization(DDA) was R$2,204 Mil.
Selling, General, & Admin. Expense(SGA) was R$8,081 Mil.
Total Current Liabilities was R$11,444 Mil.
Long-Term Debt & Capital Lease Obligation was R$21,378 Mil.
Net Income was 966.081 + 940.762 + 1111.208 + 1140.62 = R$4,159 Mil.
Non Operating Income was 44.818 + 48.998 + -14.816 + 29.122 = R$108 Mil.
Cash Flow from Operations was 766.889 + 2582.195 + 1022.311 + 2155.043 = R$6,526 Mil.
Total Receivables was R$6,532 Mil.
Revenue was 12141.247 + 12237.518 + 13035.59 + 12382.008 = R$49,796 Mil.
Gross Profit was 4015.831 + 3976.013 + 4551.445 + 4250.163 = R$16,793 Mil.
Total Current Assets was R$9,448 Mil.
Total Assets was R$66,639 Mil.
Property, Plant and Equipment(Net PPE) was R$12,417 Mil.
Depreciation, Depletion and Amortization(DDA) was R$2,272 Mil.
Selling, General, & Admin. Expense(SGA) was R$9,803 Mil.
Total Current Liabilities was R$7,058 Mil.
Long-Term Debt & Capital Lease Obligation was R$23,256 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6583.296 / 45675.217) / (6531.584 / 49796.363)
=0.144133 / 0.131166
=1.0989

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(16793.452 / 49796.363) / (15013.589 / 45675.217)
=0.337243 / 0.328703
=1.026

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11094.994 + 11896.742) / 69488.129) / (1 - (9448.4 + 12417.302) / 66638.828)
=0.669127 / 0.671877
=0.9959

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=45675.217 / 49796.363
=0.9172

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2272.199 / (2272.199 + 12417.302)) / (2203.545 / (2203.545 + 11896.742))
=0.154682 / 0.156277
=0.9898

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8081.176 / 45675.217) / (9802.894 / 49796.363)
=0.176927 / 0.19686
=0.8987

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((21378.281 + 11443.58) / 69488.129) / ((23256.399 + 7057.653) / 66638.828)
=0.472338 / 0.454901
=1.0383

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(4158.671 - 108.122 - 6526.438) / 69488.129
=-0.03563

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Quest Diagnostics has a M-score of -2.61 suggests that the company is unlikely to be a manipulator.


Quest Diagnostics Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (BSP:Q1UE34) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines